NDC 0002-6885

Baricitinib

Baricitinib

Baricitinib is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Baricitinib.

• Product ID: 0002-6885_14a2ffe3-1d7e-4d1b-ac44-1698d5f92da4
• NDC: 0002-6885
• Product Type: Human Prescription Drug
• Proprietary Name: Baricitinib
• Generic Name: Baricitinib
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2021-12-20
• Marketing Category: EMERGENCY USE AUTHORIZATION /
• Labeler Name: Eli Lilly and Company
• Substance Name: BARICITINIB
• Active Ingredient Strength: 4 mg/1
• Pharm Classes: Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0002-6885-30

30 TABLET, FILM COATED in 1 BOTTLE (0002-6885-30)

• Marketing Start Date: 2021-12-20
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Baricitinib" or generic name "Baricitinib"

NDC	Brand Name	Generic Name
0002-6885	Baricitinib	baricitinib
0002-4182	Olumiant	baricitinib
0002-4479	Olumiant	baricitinib
0002-4732	Olumiant	baricitinib